
PellePharm closes $20mm Series B round
Executive Summary
PellePharm Inc. (oncology) raised $20mm through a three-tranche Series B round that was led by BridgeBio Pharma.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
-
Drug Delivery
- Topical Delivery
-
Drug Delivery
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com